(5-Cyanobenzofuran-2-yl)boronic acid, 95.0%, 250mg

4-ethyl-5-[1-(4-fluorophenoxy)ethyl]-4H-1,2,4-triazole-3-thiol, 95.0%, 1g

(3aS,4S,6R,6aR)-4-(Iodomethyl)-6-methoxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxole, 95+%, 250mg

8-Bromo-2-(trifluoromethyl)imidazo[1,2-a]pyridine, 95+%, 5g

2,3-Dimethoxyaniline>98.0%(GC)(T)25g

tert-Butyl 3-(4-bromo-1H-pyrazol-1-yl)pyrrolidine-1-carboxylate, 97%, 1g

1,1-Di(o-tolyl)ethylene, 1g

2-Methyl-2-adamantanol>99.0%(GC)25g

1-Adamantancarbonsäure, min. 99 %, zur Synthese, 25 g, kunststoffverpackung.

2-(2-(2-(2-(4-Nitrophenoxy)ethoxy)ethoxy)ethoxy)ethanamine, 97%, 100mg

6-CHLORO-9-(2-FLUOROBENZYL)-9H-PURINE, 95.0%, 100mg

2,4-Dihydroxybenzamide, 95.0%, 5g

tert-Butyl 5-bromo-1-oxoisoindoline-2-carboxylate, 95.0%, 10g